When immunity kills: the lessons of SARS-CoV-2 outbreak
Y Taoufik, MG de Goer de Herve, S Corgnac… - Frontiers in …, 2021 - frontiersin.org
Since its emergence at the end of 2019, SARS-CoV-2 has spread worldwide at a very rapid
pace. While most infected individuals have an asymptomatic or mild disease, a minority …
pace. While most infected individuals have an asymptomatic or mild disease, a minority …
[PDF][PDF] Anti-rheumatic drugs as potential anti-inflammatory, immunomodulatory agents against COVID-19: A systematic review
Background: The effective responses of both innate and adaptive immunity are crucial in
combating novel coronavirus-2 infection. An excessive response may lead to cytokine storm …
combating novel coronavirus-2 infection. An excessive response may lead to cytokine storm …
[HTML][HTML] Фармакоэкономические аспекты лечения COVID-19
ИВ Рогова, ЕА Жидкова, ИА Попова… - …, 2021 - cyberleninka.ru
В статье предложен обзор мировых тенденций различных лечебных подходов при
COVID-19 с точки зрения фармакоэкономической эффективности. Рассматриваются …
COVID-19 с точки зрения фармакоэкономической эффективности. Рассматриваются …
[PDF][PDF] COVID-19'da Romatizmal Hastalıkların Yönetimi.
S Uslu - Journal of Tepecik Education & Research Hospital …, 2022 - jag.journalagent.com
Tüm dünyada Koronavirüs hastalığı-2019 (COVID-19) salgını küresel bir acil durum
meselesidir. Komorbiditeleri olan, ileri yaştaki ve bağışıklık sistemi zayıf olan hastalarda …
meselesidir. Komorbiditeleri olan, ileri yaştaki ve bağışıklık sistemi zayıf olan hastalarda …
[PDF][PDF] Prospects of monoclonal antibodies in COVID-19 treatment: a systematic review.
Objectives: We reviewed the types of monoclonal antibodies being repurposed for COVID-
19 therapeutics, the clinical outcomes and adverse effects so as to provide evidence the …
19 therapeutics, the clinical outcomes and adverse effects so as to provide evidence the …
Pharmacoeconomic aspects of COVID-19 treatment
IV Rogova, EA Zhidkova, IA Popova… - …, 2021 - pharmacoeconomics.ru
The article provides an overview of global trends in various treatment approaches for COVID-
19 in terms of pharmacoeconomic effectiveness. Different strategies for managing patients …
19 in terms of pharmacoeconomic effectiveness. Different strategies for managing patients …
[PDF][PDF] The Potentials of Monoclonal Antibodies as a COVID-19 Intervention Tool
COVID-19 has been ravaging the world since late December, 2019 and it is not slowing
down as the global cumulative counts of confirmed cases and fatalities continue to rise every …
down as the global cumulative counts of confirmed cases and fatalities continue to rise every …
Role of IL6 Antagonist, Tocilizumab in Treating Covid 19; A Narrative Review.
AMA Ameri - Kerbala Jorunal of Medicine, 2020 - search.ebscohost.com
Background and objective: Coronavirus disease 2019 (Covid 19) is the most severe
pandemic hit the world during the last century. Generally, the diseases course has two …
pandemic hit the world during the last century. Generally, the diseases course has two …